Category: Gov Press Releases

Following a review of the evidence, the independent expert screening committee recommends that screening for severe combined immunodeficiency (SCID) should be tried for a period of time in the NHS.

SCID refers to a number of rare inherited conditions which affect the development of a baby’s white blood cells – these are an important part of the immune system and make it difficult for babies to fight infections. Around 15 to 25 babies are born with the condition every year in the UK. The treatment is a bone marrow transplant, which can repair the damaged immune system.

The trial period will allow the committee to gather information about the practicalities and likely effect of screening before a final recommendation is made on whether to include SCID in the NHS newborn bloodspot screening programme.

Screening, as part of the newborn blood spot screening programme, would look for babies with low numbers of white blood cells as a sign that they may have SCID, but the independent committee found that more evidence is required on whether screening for the condition would do more good than harm, as it is not clear:

• how many babies may be diagnosed with having the condition when they do not (false positives)
• what care and treatment to offer babies with other conditions that cause low numbers of white blood cells

Professor Anne Mackie, Director of Programmes for the UK National Screening Committee (UK NSC), said:

There is still uncertainty whether screening for SCID would lead to babies who are well being diagnosed with the condition and receiving unnecessary treatment. It’s also unclear what would be the best care and treatment to offer babies who don’t have SCID, but are found to have other immune deficiency conditions.

We need to find out if screening for SCID would provide overall benefits or do more harm by falsely diagnosing those without the condition. That is why the committee has recommended screening over a trial-period which will help them decide whether NHS screening for SCID should be recommended.

After careful consideration of the evidence, the UK NSC did not recommend introducing screening programmes for the following conditions:

Newborn screening for Cytomegalovirus (CMV)

Cytomegalovirus is a common viral infection found in children and adults which doesn’t always have symptoms nor need to be treated. If it is passed from mother to baby during pregnancy this is called congenital CMV infection. Screening was not currently recommended as it is not possible to know which babies are going to develop long-term health problems. So more research is needed to distinguish between babies that will suffer from the infection and babies that will not.

Human T-cell lymphotropic virus (HTLV) in pregnancy

Human T-cell lymphotropic virus (HTLV) can be passed from person to person through blood transfusion or unprotected sexual contact. HTLV infection can also be passed from mother to child. This is usually through breastfeeding for longer than 6 months. Screening was not recommended as the risk of a mother passing HTLV to their child through breastfeeding is low unless breastfeeding is continued beyond 6 months.

Newborn screening for biliary atresia

This is a rare condition that causes the bile ducts to become blocked or inflamed. Bile is a digestive fluid necessary to digest fatty acids and vitamins. If it cannot drain away from the liver, bile can build up and cause serious liver damage in the early years. Screening was not recommended as there is no reliable test which could be used to find babies with biliary atresia in the first week of life.

Iron deficiency anaemia (IDA) in children under 5 years

IDA is the most common form of anaemia and occurs when iron levels are too low to support the production of red blood cells, usually because of a lack of iron in the diet. Children aged under-5 are especially at risk. It is possible that IDA may affect a child’s development, but this is not known for certain. Screening was not recommended as it is not known how many children in the UK are affected. It is uncertain whether IDA in children under the age of 5 causes adverse developmental outcomes and whether it gets better without treatment. Also a suitable test is not yet available.

The UK NSC will review all these recommendations again in 3 years as part of its regular evidence review process or earlier if significant new evidence becomes available.

The latest screening recommendations were made at the UK NSC meeting on 25 October 2017, the minutes of which are published today (6 December 2017).

Background

1. The UK National Screening Committee is independent of, but supported by, Public Health England.
2. View the detailed summaries of the recommendations for all of the conditions mentioned.
3. Public Health England exists to protect and improve the nation’s health and wellbeing, and reduce health inequalities. We do this through world-leading science, knowledge and intelligence, advocacy, partnerships and the delivery of specialist public health services. We are an executive agency of the Department of Health, and a distinct delivery organisation with operational autonomy to advise and support government, local authorities and the NHS in a professionally independent manner.

The next phase of the landing obligation, also known as the ‘discard ban’, comes into force from 1 January 2018.

The Marine Management Organisation has provided guidance for the fishing industry to help them comply with the next phase of the discard ban. This outlines which fish come under the landing obligation, what fishermen have to do with them on board, and which can be sold for human consumption.

The new developments will see more fishing vessels captured by the landing obligation as thresholds for inclusion are reduced or removed for some fish species. There are also changes around exemptions for some vessels, in particular where scientific evidence indicates that an increase in selectivity of species is hard to achieve and around unwanted catches for certain gear types.

For 2018, the UK Government has worked to maintain, and in some cases extend, exemptions allowing fish with high survival rates to be discarded as well as some unwanted catches that are difficult to avoid. In addition, the MMO will continue to apply a fair and proportionate approach to enforcement.

The development is the latest phase of the wider discard ban which will bring an end to the practice of throwing dead fish back into the sea. The landing obligation was initially introduced in January 2015 for certain pelagic fisheries. All quota species will be phased in under landing obligation rules by 2019.

Guidance on the landing obligation can also be found on the European Commission’s website.

Financial support from the European Maritime Fisheries Fund (EMFF) may be available to help fishermen adapt and comply with the landing obligation. Further information is available on the MMO website.

Trustees should take steps to ensure no one who comes into contact with their charity suffers distress or harm, as well as safeguarding children and adults at risk, says regulator of charities.

The Charity Commission’s new safeguarding strategy says that safeguarding is a key governance priority for all charities, not just those working with groups traditionally considered at risk.

The strategy explains that trustees should ensure their charity provides a safe environment for staff, volunteers, and anyone who comes into contact with it.

It also makes clear that safeguarding goes beyond preventing physical abuse, and includes protecting people from harm generally, including neglect, emotional abuse, exploitation, radicalisation, and the consequences of the misuse of personal data.

Where a charity funds other organisations, such as overseas partners, that work with children or adults at risk, its trustees should carry out appropriate due diligence so that they can be confident that their partner has in place appropriate safeguarding policies and procedures.

Safeguarding is one of the three areas of risk facing charities that the Commission priorities in its work, alongside fraud and financial abuse and mismanagement and the extremist and terrorist abuse of charities. It says trustees always remain responsible for safeguarding, even if some aspects of it are delegated to staff.

Michelle Russell, Director of Investigations, Monitoring and Enforcement at the Commission, says what trustees need to do in practice will depend on their charity’s circumstances:

The public rightly expect all charities to be safe environments. So all trustees should make safeguarding a governance priority. Of course, what trustees do in practice will depend on the context of their charity’s work, and trustees should take a proportionate approach. Charities working with vulnerable groups such as children and adults at risk for example, will need to ensure their safeguarding policies and practices comply with relevant safeguarding legislation and regulations.

But all trustees should think about the people that come into contact with their charity and consider the steps they can take to prevent them from coming to harm.

Recent accusations of harassment in the work place, including against some charities, demonstrate how vital it is that trustees are alive to the need to protect and safeguard all those involved in or affected by their work.

The Commission recently found that some veterans’ charities were not taking adequate steps to protect their beneficiaries; the Commission says this was, in part, because the trustees did not consider certain veterans as being vulnerable.

The new strategy sets out the Commission’s approach to safeguarding, and explains what trustees’ charity law duties mean in the context of safeguarding. It replaces a previous strategy.

Ends

PR 78/17

Notes to Editors

1. The Charity Commission is the independent regulator of charities in England and Wales. To find out more about our work, see the about us page on GOV.UK.
2. The Commission takes a risk-based approach to safeguarding matters and its role is to ensure that trustees of charities work with or provide services to vulnerable beneficiaries comply with their legal duties, and take reasonable steps to protect them and other persons that come into contact with the charity from harm and minimise the risk of abuse.
3. The Commission is not responsible for dealing with incidents of actual abuse and does not administer safeguarding legislation. It cannot prosecute or bring criminal proceedings, although it can and does refer any concerns to the police, local authorities and the Disclosure and Barring Service (‘DBS’) each of which has particular statutory functions.

• Business Secretary Greg Clark and Health Secretary Jeremy Hunt have today (Wednesday 6 December) announced a Sector Deal with the Life Sciences sector.
• Significant investment by 25 organisations from across the sector and supported by government will ensure the UK is at the forefront of developing new innovative treatments and medical technologies that improve patient lives.
• The transformative Sector Deal gives the life sciences sector and government an agreed set of strategic goals that will ensure the UK builds on its exceptional reputation for science and research, genomics and clinical trials.

A transformative Sector Deal between the UK life sciences sector and the government has today (Wednesday 6 December) been announced. This draws substantial investment into the sector from across the world, ensuring that the next wave of breakthrough treatments, innovative medical research and technologies, and high skilled jobs are created in Britain.

A key part of the Industrial Strategy White Paper, the Life Sciences Sector Deal sets out an agreed strategic vision, built on co-investment, for the government and UK life sciences that will modernise the industry, boost businesses large and small within it, and ensure the sector is perfectly positioned to respond to the challenges and opportunities of demographic change and pioneering research and development.

The deal brings together a number of significant commitments and investments into the UK by 25 global organisations from across the sector, including a major investment by global healthcare firm MSD, known as Merck and Co. Inc. in the US. The investment by MSD will include a new world-leading life sciences discovery research facility and headquarters in the UK, supporting 950 jobs including 150 new high-skilled and high-value research roles.

Business Secretary Greg Clark said:

Across the world, advances in science and technology are transforming the way we live our lives. Nowhere is innovation more life-changing than in medicine, healthcare and its associated fields.

New discoveries and the applications of new technologies are making diagnoses earlier and more accurate, making new treatments available and existing ones more effective; and making care more beneficial and comforting.

The United Kingdom is extraordinarily well-placed to play a leading role in this revolution in the life sciences. Our universities and research institutes rank among the best in the world. They nurture and attract some of the most inventive people on earth.

We are home to many of the most successful global life sciences businesses and we are also a hotbed of new businesses – springing up to bring new discoveries and techniques to a wider market. Our National Health Service is a prized national asset – the nation’s biggest employer and a deep source of learning and of translating discoveries into care.

That is what our Industrial Strategy sets out to support and achieve. So it is appropriate that the first Sector Deal of our Industrial Strategy should be with the Life Sciences sector.

Health Secretary Jeremy Hunt said:

The UK has a huge amount to offer the life sciences sector, combining globally renowned scientific research bases with our world leading NHS which allows innovators to test and refine products at scale.

Today proves that life science organisations of all sizes will continue to grow and thrive in the coming years, which means NHS patients will continue to be at the front of the queue for new treatments.

The government and industry have worked extensively since the launch of the Industrial Strategy Green Paper to secure the deal, with Prof Sir John Bell convening industry involvement in the deal. Yesterday evening, representatives from the companies involved in the deal attended an event at 10 Downing Street to celebrate the success of the sector, attended by Business Secretary Greg Clark and Health Secretary Jeremy Hunt.

Secretary of State for International Trade, Dr Liam Fox said:

Today’s deal is a clear signal to life science investors around the world that the UK is open for business and a world leader in scientific innovation. The Department of International Trade has provided dedicated support to make this investment possible, and that offer is available to all investors through our global network.

As an international economic department our role is to promote the UK as a premier destination to invest, and we are ready to work with potential investors to secure our capital requirements for infrastructure, regeneration and innovative projects in every part of the country.

Regius Professor of Medicine, University of Oxford, Prof Sir John Bell said:

This Life Sciences Sector Deal demonstrates how powerful it can be to have industry, the NHS, the research community and charities all working together to provide important new insights that can lead to the discovery and implementation of novel innovations for healthcare.

It represents a significant change in both pace and culture that I hope will lead to a flow of such investments into the future.

Key themes of the deal

The deal sets out a plan for key priorities for the sector going forward, with a vision and strategy that are aligned to the pillars of the Industrial Strategy and the themes of Sir John Bell’s Life Sciences Industrial Strategy. It includes action on the technologies of the future and the evolution of clinical trials, alongside government support for direct and indirect investment to support growth.

Each theme sets out a programme of action:

• research: building on the UK’s position as a world leader in biomedical discovery with major inward investments, including MSD announcing a new state-of-the-art R&D hub in London
• technologies of the future: the deal outlines plans to grow the UK’s international reputation for pioneering early diagnostics and genomics programmes, with a government investment from the Industrial Strategy Challenge Fund of up to £210 million, subject to business case. This will contribute to the genomics programme in partnership with organisations including GSK and AstraZeneca and launch a trail-blazing AI programme to develop digital pathology and radiology programmes in partnership with industry, embedded in the NHS
• the evolution of UK clinical trials capabilities: ensuring that the UK continues to lead the world with its clinical trials, through innovative new trials platforms and investments in the UK’s digital evidence collection abilities, combined with a progressive regulatory system. The Medicines Company is today announcing new trials that will use novel methodologies
• business environment: the government has committed £162m, through the first wave of the Industrial Strategy Challenge Fund, to develop innovative medicines manufacturing infrastructure and enable SMEs to manufacture advanced therapies. This includes two new national centres – Medicines Manufacturing Innovation Centre and a Vaccines centre – adding to the existing national centres and three advanced therapy treatment centres co-located in hospitals across the UK as well as funding for viral vectors.

Investment across the UK

The UK has a number of world-class life sciences clusters across the country and today’s deal delivers on the Industrial Strategy’s aim to distribute growth and opportunity across the country, with pioneering investments in Manchester, Leeds, Sheffield, Glasgow, South Wales and the South East.

The Sector Deal, published on GOV.UK at 09.00am, sets out full details of the agreed strategy with details of each investment coming into the UK. It includes:

• MSD: a commitment by MSD to establish a state-of-the-art life sciences discovery research facility in London, focussed on early bioscience discovery and entrepreneurial innovation. MSD believes that locating a research facility in London will expand its opportunity to engage with leading researchers in the UK and Europe
• Johnson & Johnson: one of the Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Pharmaceutica NV, and the University of Oxford intend to collaborate on novel clinical trial methodologies in the UK; these would include platform trials, focused on mental health disorders such as depression
• Medicines Company: The Medicines Company has initiated two projects – one with the University of Oxford to perform a large multinational cardiovascular disease clinical trial and another with The Greater Manchester Health and Social Care Partnership to improve the understanding, management and economics of cardiovascular disease.
• GSK and AstraZeneca: significant investments by GSK and AstraZeneca in initiatives to harness advances in genetic research in the development of medicines

Government announced in August £162 million of funding focused on medicines manufacturing from the first wave of the Industrial Strategy Challenge Fund and an additional £86m as part of the response to the Accelerated Access Review. Building on this, as part of the Industrial Strategy White Paper, government committed through ISCF’s Wave 2 up to £210m, dependent on businesses cases, for Early Diagnostics programmes including funding for Genomics research and using AI with digital pathology and radiology.

Dr Roger M. Perlmutter, President of MSD Research Laboratories said:

For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases.

The announcement of our plans to bring a new Discovery Centre to London, as part of the Life Sciences Sector Deal, will enable us to collaborate with scientists conducting promising emerging science in the UK.

Our new site will combine MSD’s powerful and proven R&D engine with the cutting edge technologies and deep discovery capabilities afforded by the biomedical research community in the golden triangle of London-Oxford-Cambridge as well as access to the continental European life science ecosystem.

Dr Richard Mason, Head of Johnson & Johnson Innovation, EMEA said:

At Johnson & Johnson we collaborate with the brightest minds in every field to drive innovation, change and transformation in healthcare.

We are proud to be part of today’s sector deal, demonstrating our commitment to UK life sciences and to ensuring that the UK remains at the forefront of new innovations.

Our partnership with Oxford University will focus on mental health disorders, which is a priority area of focus for the NHS.

Phil Thomson, President, Global Affairs, GSK, said:

The UK has a world class life sciences sector, but that will only continue to thrive through a strong partnership of Government, industry and academia.

This Sector Deal contains a number of very practical commitments to strengthen the UK’s life science base and make it more attractive to international investment in areas such as clinical trials and high-tech research.

Ultimately, this should provide benefits to the economy and create jobs. We look forward to seeing further initiatives result from this strategy for the sector.

Mene Pangalos, Executive Vice-President, Innovative Medicines and Early Development (IMED) Biotech Unit and Business Development, at AstraZeneca, said:

Establishing the UK as a global leader in genomics and precision medicine closely aligns with AstraZeneca’s ongoing research programmes and ambitions for the future of medicine.

The UK is one of the best places in the world for cutting-edge science, as is reflected in AstraZeneca’s investment of £500 million in our new strategic R&D centre and global headquarters in Cambridge.

The Life Sciences Sector Deal will complement the work of our existing partnerships with Genomics England and others to analyse two million genomes by 2026, helping us to unlock the full benefits that targeted medicines present for patients and the NHS.

Clive Meanwell, Chief Executive Officer, The Medicines Company, said

Our exciting and productive partnerships with the University of Oxford and with The Greater Manchester Health and Social Care Partnership demonstrate the significant potential for The Life Sciences Industrial Strategy to drive growth through new forms of collaboration.

We also believe that our work with these two groups demonstrates the UK’s unique capabilities in clinical trials and in digital healthcare data systems which are rapidly emerging as critical capabilities in the life-science sector worldwide.

Peter Ellingworth, Chief Executive Officer, ABHI, said

I welcome today’s announcement and with continued Government backing, the UK will be a world leader in developing new medical treatments and technologies in the Life Sciences.

“This deal will not only benefit the MedTech sector, but the healthcare system and the economy as a whole. If we are to ensure the value our industry provides is realised, high levels of sustained NHS collaboration will be crucial to its success.”

Mike Thompson, Chief Executive Officer, ABPI, said:

Today’s announcements are a great start towards industry and Government working together to deliver the long-term strategic roadmap set out in the Life Sciences Industrial Strategy.

These are smart investments for the future that acknowledge the Government’s willingness to build upon the UK’s global strength in R&D, our leadership in new technologies such as genomic medicine and the potential that exists in making the best use of health data.

If we get this right – if the Life Sciences Industrial Strategy is implemented in full – the UK can open itself up to be at the forefront of cutting-edge clinical research. NHS hospitals will reap the benefits of global clinical trials and the financial rewards they bring; doctors can prescribe the latest treatments and patients will get the best standard of care. This ecosystem will deliver for everyone.

Next year could be a transformative year for the NHS as we work together to deliver this innovation to underpin a more productive health service.

Following news that the Chennai Six have been granted the necessary permissions to leave India, Foreign Secretary Boris Johnson said:

It is wonderful news that the men are returning to the UK.

The Foreign Office has worked unstintingly on this case, lobbying on the men’s behalf, visiting them in prison, updating their families, and maintaining close contact with their legal team.

I pay tribute to those who have campaigned for the men, who will be delighted to see them return home after being separated for so long.

Further information

• Follow the Foreign Secretary on Twitter @BorisJohnson and Facebook
• Follow the Foreign Office on Twitter @foreignoffice and Facebook
• Follow the Foreign Office on Instagram, YouTube and LinkedIn

A Downing Street spokesperson said:

The Prime Minister met with Prime Minister Rajoy of Spain this afternoon. Theresa May began by restating the UK’s support for the Spanish Government on the issue of Catalonia – stating the rule of law must be upheld and the Spanish constitution respected.

The Prime Minister gave an update on the Brexit negotiations, confirming that she would be reconvening talks with the European Commission before the end of the week. She said both sides were positive about the progress that could be made ahead of December European Council. Prime Minister Rajoy said he shared the desire to move talks on to the next stage of negotiations as quickly as possible and that Spain would remain a constructive partner.

Prime Minister Rajoy spoke about the deep and strong relationship between Spain and the UK, referring to the significant investment that Spanish companies have made in the UK and the fruitful trading relationship. The Prime Minister welcomed views on how we could continue a good trading relationship between the two countries after Brexit and ensure this was as frictionless as possible.

The two leaders spoke about foreign policy and the threat of Russia, agreeing that it was important to maintain a collective and rigorous approach to sanctions and to counter disinformation.

They also spoke about increasing co-operation to counter the growing threat of terrorism. The Prime Minister outlined that the nature of terrorism was changing and how the internet and social media was providing terrorists with an extra tool to accelerate and amplify the terror they seek to spread.

Lastly, Prime Minister Rajoy raised the issue of the abhorrent treatment of Libyan people being smuggled into Europe and the ongoing efforts to help repatriate them. The Prime Minister said that this was an important challenge and she wanted to work closely with her European colleagues now and in the future to see what more could be done by, for example, improving conditions in the country of origin.

During November, there were eight new detentions of foreign flagged vessels in a UK port. seven vessels remained under detention from previous months. A total of seven vessels remain under detention at the end of November.

1. In response to one of the recommendations of Lord Donaldson’s inquiry into the prevention of pollution from merchant shipping, and in compliance with the EU Directive on Port State Control (2009/16/EC as amended), the Maritime and Coastguard agency (MCA) publishes details of the foreign flagged vessels detained in UK ports each month.
2. The UK is part of a regional agreement on port state control known as the Paris Memorandum of Understanding on Port State Control (Paris MOU) and information on all ships that are inspected is held centrally in an electronic database known as THETIS. This allows the ships with a high risk rating and poor detention records to be targeted for future inspection.
3. Inspections of foreign flagged ships in UK ports are undertaken by surveyors from the Maritime and Coastguard Agency. When a ship is found to be not in compliance with applicable convention requirements, a deficiency may be raised. If any of their deficiencies are so serious they have to be rectified before departure, then the ship will be detained.
4. All deficiencies should be rectified before departure if at all possible.
5. When applicable, the list includes those passenger craft prevented from operating under the provisions of the EU Directive on Mandatory Surveys for the safe operation of regular Ro-Ro ferry and high speed passenger craft services (1999/35/EU).

Notes on the list of detentions

• Full details of the ship.
  The accompanying detention list shows ship’s International Maritime Organization (IMO) number which is unchanging throughout the ship’s life and uniquely identifies it. It also shows the ship’s name and flag state at the time of its inspection.
• Company.
  The company shown in the vessel’s Safety Management Certificate (SMC) or if there is no SMC, then the party otherwise believed to be responsible for the safety of the ship at the time of inspection.
• Classification Society.
  The list shows the Classification Society responsible for classing the ship only.
• Recognised Organisation.
  Responsible for conducting the statutory surveys: and issuing statutory certificates on behalf of the Flag State
• White (WL), Grey (GL) and Black lists (BL) are issued by the Paris MoU on 01 July each year and shows the performance of flag State.

SHIPS DETAINED IN NOVEMBER 2017

Vessel Name: DOLLY C

GT: 652

IMO: 7222310

Flag: St Vincent & Grenadines (Grey List)

Company: No Information

Classification Society: No Information

Recognised Organisation: No Information

Recognised Organisation for ISM Doc: No Information

Recognised Organisation for ISM SMC: No Information

Date and Place of Detention: 29th November 2017 at Falmouth

Summary: Eight deficiencies with eight grounds for detention

Defective item	Nature of defect	Ground for Detention
01209 – Manning specified by the minimum safe manning doc	Missing	Yes
01214 – Endorsement by flagstate	Missing	Yes
07111 – Personal equipment for fire safety	Missing	Yes
01199 – Other (Certificates)	Other	Yes
11116 – Distress flares	Missing	Yes
05103 – Main installation	Missing equipment	Yes
10105 – Magnetic compass	Not as required	Yes
14103 – Segregation of oil and water ballast	Not as required	Yes

This vessel was still detained on 30th November 2017

Vessel Name: HORIZON GEOBAY

GT: 3502

IMO: 7801556

Flag: Panama (White List)

Company: Horizon Survey Co

Classification Society: ABS

Recognised Organisation: ABS/DNV GL

Recognised Organisation for ISM Doc: BV

Recognised Organisation for ISM SMC: BV

Date and Place of Detention: 23th November 2017 at Aberdeen

Summary: Twenty deficiencies with two grounds for detention

Defective item	Nature of defect	Ground for Detention
10101 – Pilot ladders and hoist/pilot transfer arrangements	Unsafe	No
99101 – Other safety in general	Other	No
10106 – Compass correction log	Not as required	No
06199 – Other (cargo)	Other	No
10114 – Voyage data recorder (VDR)/Simplified Voyage data recorder (S_VDR)	Not as required	No
11118 – Lifejackets inc. provision and disposition	Not as required	No
18408 – Electrical	Unsafe	No
07105 – Fire doors/openings in fire-resisting divisions	Unsafe	No
07105 – Fire doors/openings in fire-resisting divisions	Not as required	No
01213 – Evidence of Basic Training	Missing	Yes
99101 – Other safety in general	Other	No
99101 – Other safety in general	Other	No
01126 – Document of compliance dangerous goods	Missing	No
10127 – Voyage or passage plan	Not as required	No
10129 – Navigation records	Not as required	No
16101 – Security related defects	Not as required	No
05115 – Radio log (diary)	Not as required	No
15150 – ISM	Not as required	Yes
10138 – BNWAS	Malfunctioning	No
07105 – Fire doors/openings in fire-resisting divisions	Malfunctioning	No

This vessel was still detained on 30th November 2017

Vessel Name: SSI EXPEDITION

GT: 32987

IMO: 9446714

Flag: Marshall Islands (White List)

Company: Atlantis

Classification Society: LR

Recognised Organisation: LR

Recognised Organisation for ISM Doc: LR

Recognised Organisation for ISM SMC: LR

Date and Place of Detention: 24th November 2017 at Teesport

Summary: Twenty deficiencies with three grounds for detention

Defective item	Nature of defect	Ground for Detention
07109 – Fixed fire extinguishing installation	Not as required	No
10109 – Lights, shapes, sound-signals	Inoperative	No
03108 – Ventilators, air pipes, casing	Corroded	No
10105 – Magnetic compass	Not as required	No
11101 – Lifeboats	Not properly maintained	No
11113 – Launching arrangements for rescue boats	Not as required	No
07108 – Ready availability of fire fighting equipment	Inoperative	No
11110 – Stowage and provision of liferafts	HRU improp. Fitted	No
07103 – Division – decks, bulkheads and penetrations	Not as required	No
03106 – Windows, sidescuttles and deadlights	Cracked	No
18312 – Galley, handlingroom (maintenance)	Missing	No
18407 – Lighting (Working spaces)	Inoperative	No
18408 – Electrical	Not as required	No
02117 – Decks – corrosion	Holed	Yes
03104 – Cargo & other hatchways	Damaged	No
07112 – Emergency escape breathing device and disposition	Not as required	No
03107 – Doors	Corroded	No
18314 – Provisions quality	Missing	No
07114 – Remote means of control (opening, pumps, ventilation, etc.) Machinery spaces	Not as required	Yes
15150 – ISM	Not as required	Yes

This vessel was released on 27th November 2017

Vessel Name: OCEAN SPIRIT

GT: 1717

IMO: 8325793

Flag: Russian Federation (White List)

Company: F2 Ltd

Classification Society: RINA

Recognised Organisation: RINA

Recognised Organisation for ISM Doc: RMRS

Recognised Organisation for ISM SMC: RMRS

Date and Place of Detention: 21st November 2017 at Aberdeen

Summary: Fourteen deficiencies with eight grounds for detention

Defective item	Nature of defect	Ground for Detention
08110 – Closing water-tight doors alarm	Inoperative	Yes
10138 – BNWAS	Inadequate	No
10138 – BNWAS	Malfunctioning	Yes
1110 – Rescue boats	Not ready for use	Yes
10101 – Pilot ladders and hoist/pilot transfer arrangements	Unsafe	No
99101 – Other safety in general	Other	Yes
18317 – Food personal hygiene	Not hygienic	No
10118 – Speed and distance indicator	Inoperative	Yes
13102 – Auxilary engine	Not as required	No
07106 – Fire detection and alarm system	Not as required	Yes
07105 – Fire doors/openings in fire-resisting divisions	Not as required	No
15150 – ISM	Not as required	Yes
10117 – Echo sounder	Inoperative	Yes
18418 – Winches & capstans	Missing	No

This vessel was still detained on 30th November 2017

Vessel Name: ANJA

GT: 2996

IMO: 9116187

Flag: Netherlands (White List)

Company: Holwerda Ship Management BV

Classification Society: DNV GL

Recognised Organisation: DNV GL

Recognised Organisation for ISM Doc: DNV GL

Recognised Organisation for ISM SMC: DNV GL

Date and Place of Detention: 7th November 2017 at Immingham

Summary: Sixteen deficiencies with eight grounds for detention

Defective item	Nature of defect	Ground for Detention
Other		No
03102 – Freeboard marks	Not readable	No
07105 – Fir doors/openings in fire resisting divisions	Not as required	Yes
06101 – Cargo Securing Manual	Not as required	No
07112 – Emergency escape breathing device and disposition	Not properly stowed	NO
18409 – Dangerous areas	Unsafe	Yes
18416 – Ropes and wires	Not as required	No
18325 – Training and qualification of ship’s cook	Not as required	No
10127 – Voyage or passage plan	Not as required	Yes
10133 – Bridge operation	Lack of familiarity	Yes
04109 – Fire drills	Lack of training	Yes
04108 – Muster list	Incomplete	Yes
09235 – Fitness for duty – work and drest hours	Work hours exceeded	Yes
01306 – Shipboard working arrangements	Not as required	No
10136 – Establilshment of working language on board	Not established	No
15150 – ISM	Not as required	Yes

This vessel was released on 10th November 2017

Vessel Name: DS SOFIE BULKER

GT: 17663

IMO: 9310604

Flag: Marshall Islands (White List)
Company: Dramar Denizciuk Ticaret AS

Classification Society: NKK

Recognised Organisation: NKK

Recognised Organisation for ISM Doc: NKK

Recognised Organisation for ISM SMC: NKK

Date and Place of Detention: 7th November 2017 at Tilbury

Summary: Seven deficiencies with one grounds for detention

Defective item	Nature of defect	Ground for Detention
15150 – ISM	Not as required	No
01308 – Record of seafarers’ daily hours of work or rest	Incorrect entries	No
01220 – Seafarers’ employment agreement (SEA)	Invalid	Yes
07105 – Fire doors/opening in fire-resisting divisions	Not as required	No
18203 – Wages	Not according SEA	No
10111 – Charts	Missing	No
02107 – Ballast, fuel and other tanks	Not as required	No

This vessel was released on 10th November 2017

Vessel Name: CETUS STAR

GT: 19828

IMO: 9278741

Flag: Malta (White List)

Company: Stam Shipping SA

Classification Society: NKK

Recognised Organisation: NKK

Recognised Organisation for ISM Doc: NKK

Recognised Organisation for ISM SMC: NKK

Date and Place of Detention: 3rd November 2017 at Liverpool

Summary: Eleven deficiencies with two grounds for detention

Defective item	Nature of defect	Ground for Detention
10111 – Charts	Missing	Yes
10127 – Voyage or passage plan	Not as required	No
04109 – Fire drills	Lack of control	No
10105 – Magnetic compass	Not as required	No
04103 – Emergency, lighting, batteries and switches	Inoperative	No
07113 – Fire pumps and its pipes	Not as required	No
07105 – Fire doors/openings in fire-resisting divisions	Not as required	No
02105 – Steering gear	Not as required	No
13102 – Auxiliary engine	Not as required	No
13101 – Propulsion main engine	Not as required	No
02101 – Closing devices/watertight doors	Not as required	No
15150 – ISM	Not as required	Yes
13104 – Bilge pumping arrangements	Not as required	No
01326 – Stability information booklet	Not as required	No

This vessel was released on 7th November 2017

Vessel Name: KOMET III

GT: 4169

IMO: 8919831

Flag: Antigua & Barbuda (White List)

Company: Planet Schiffahrts GmBH

Classification Society: RINA

Recognised Organisation: RINA/BV/GL

Recognised Organisation for ISM Doc: BV

Recognised Organisation for ISM SMC: BV

Date and Place of Detention: 2nd November 2017 at Ipswich

Summary: Twenty one deficiencies with seven grounds for detention

Defective item	Nature of defect	Ground for Detention
10111 – Charts	Missing	Yes
10111 – Charts	Not updated	Yes
10127 – Voyage or passage plan	Not as required	Yes
10135 – Monitoring of voyage or passage plan	Not as required	Yes
14104 – Oil filtering equipment	Inoperative	Yes
18312 – Galley, handling room (maintenance)	Not as required	No
11124 – Embarkation arrangement survival craft	Not properly maintained	No
01308 – Record of seafarers’ daily hours of work or rest	Incorrect entries	No
01218 – Medical certificate	not properly filled	No
04118 – Enclosed space entry and rescue drill	Not carried out	No
01315 – Oil record book	Not as required	No
10133 – Bridge operation	Lack of familiarity	No
11117 – Lifebuoys incl. provision and disposition	Not as required	No
07105 – Fire doors/openings in fire-resisting divisions	Unsafe	No
18407 – Lighting (Working spaces)	Insufficient	No
18315 – Provisions quality and nutritional value	Not as required	No
07199 – Other (fire safety)	Other	No
18401 – Medical equipment, medical chest, medical guide	Expired	No
10109 – Lights, shapes, sound signals	Damaged	No
07118 – International shore connection	Not as required	No
15150 – ISM	Not as required	Yes

This vessel was released on 8th November 2017

DETENTIONS CARRIED OVER FROM PREVIOUS MONTHS

Vessel Name: APELLA

GT: 662

IMO: 7607613

Flag: Sierra Leone (Black List)

Company: 4M Lojistir Hizmetieri Ltd

Classification Society: PSCO

Recognised Organisation: PSCO

Recognised Organisation for ISM Doc: PSCO

Recognised Organisation for ISM SMC: PSCO

Date and Place of Detention: 27th October 2017 at Plymouth

Summary: Twenty deficiencies with eighteen grounds for detention

Defective item	Nature of defect	Ground for Detention
01137 – Civil liability for Bunker oil pollution damage cert	Missing	Yes
01139 – Maritime Labour Certificate	Missing	Yes
01106 – Document of Compliance	Missing	Yes
01122 – International ship security certificate	Missing	Yes
01113 – Minimum Safe Manning Document	Entries missing	Yes
01123 – Continuous Synopsis Record	Invalid	No
01209 – Manning specified by the Minimum Safe Manning document	Not as required	Yes
01214 – Endorsement by flagstate	Missing	Yes
07110 – Fire fighting equipment and appliances	Not properly maintained	No
05118 – Operation of GMDSS	Lack of familiarity	Yes
10112 – Electronic charts (ECDIS)	Not as required	Yes
10116 – Nautical publications	Missing	Yes
18201 – Fitness for duty – work and rest hours	Not as required	Yes
04108 – Muster List	Not updated	Yes
01326 – Stability information booklet	Not approved	Yes
01315 – Oil record book	Entries Missing	Yes
11116 – Distress flares	Expired	Yes
13102 – Auxiliary engine	Not as required	Yes
11104 – Rescue boats	Not properly maintained	Yes
07105 – Fire doors/opening in fire-resisting divisions	Missing	Yes

This vessel was released on 22nd November 2017

Vessel Name: BLUE ALFA

GT: 1887

IMO: 7921007

Flag: Denmark (White List)

Company: Blue Star Line

Classification Society: RINA

Recognised Organisation: RINA

Recognised Organisation for ISM Doc: DNV GL

Recognised Organisation for ISM SMC: DNV GL

Date and Place of Detention: 29th October 2017 at Aberdeen

Summary: Fifteen deficiencies with five grounds for detention

Defective item	Nature of defect	Ground for Detention
02109 – Permanent means of access	Not properly maintained	No
10105 – Magnetic compass	Not as required	No
10105 – Magnetic compass	Not as required	No
10105 – Magnetic compass	Not as required	No
10104 – Gyro compass	Inoperative	No
18408 – Electrical	Not as required	No
01101 – Cargo ship safety equipment (including exemption)	Not properly filled	No
10109 – Lights, shape, sound signals	Inoperative	No
01201 – Certificate – for master and officers	Missing	Yes
10133 – Bridge operation	Lack of familiarity	Yes
10110 – Signalling lamp	Missing	No
07125 – Evaluation of crew performance (fire drill)	Lack of training	Yes
07125 – Evaluation of crew performance (fire drill)	Lack of training	Yes
18201 – Fitness for duty, work and rest	Unfit for duty	No
15150 – ISM	Not as required	Yes

This vessel was released on 7th November 2017

Vessel Name: REGGAE

GT: 1567

IMO: 8500408

Flag: Panama (White list)

Company: Voda Denizcilik Ve Districet Ltd

Classification Society: NKK

Recognised Organisation: NKK

Recognised Organisation for ISM Doc: National Shipping Adjuster Inc

Recognised Organisation for ISM SMC: NKK

Date and Place of Detention: 27th June 2017 at Leith

Summary: Nineteen deficiencies with four grounds for detention

Defective item	Nature of defect	Ground for Detention
07112 – Emergency escape breathing device and disposition	Not as required	No
18425 – Access/structural features (ship)	Missing equipment	No
04109 – Fire drills	Lack of training	No
04108 – Muster List	Incomplete	No
10105 – Magnetic compass	Not readable	No
09232 – Cleanliness of engine room	Insufficient	No
15150 – ISM	Not as required	No
03108 – Ventilators, air pipes, casing	Damaged	No
02101 – Closing devices/watertight doors	Inoperative	No
07105 – Fire doors/openings in fire-resisting divisions	Not as required	No
18203 – Wages	Not according SEA	Yes
11117 – Lifebuoys incl. provision and disposition	Missing	No
02105 – Steering gear	Not as required	No
11108 – Inflatable liferafts	Insufficient	No
01220 – Seafarers’ employment agreement (SEA)	Not as required	Yes
18314 – Provision quantity	Insufficient	Yes
18204 – Calculation and payment of wages	Not according SEA	Yes
10116 – Nautical publications	Not updated	No
13102 – Auxiliary engine	Missing	No

This vessel was released on 2nd November 2017

Vessel Name: TAHSIN

GT: 1598

IMO: 9055187

Flag: Panama (White list)

Company: Voda Denizcilik IC Dis Tacaret Ltd

Classification Society: NKK

Recognised Organisation: NKK/NASHA

Recognised Organisation for ISM Doc: NKK

Recognised Organisation for ISM SMC: NKK

Date and Place of Detention: 2nd June at Sharpness

Summary: Twelve deficiencies with eight grounds for detention

Defective item	Nature of defect	Ground for Detention
18327 – Ventilation (working spaces)	Inoperative	Yes
10116 – Nautical publications	Missing	Yes
01214 – Endorsement by flagstate	Missing	No
01220 – Seafarers’ employment agreement (SEA)	Invalid	Yes
11128 – Line-throwing appliance	Expired	No
11129 – Operational readiness of lifesaving appliances	Expired	No
01202 – Certificate for rating for watching	Missing	Yes
18203 – Wages	Not according SEA	Yes
10111 – Charts	Missing	Yes
05106 – INMARSAT ship earth station	Not as required	Yes
15150 – ISM	Not as required	Yes
03104 – Cargo & other hatchways	Damaged	No

This vessel was still detained on 30th November 2017

Vessel Name: MALAVIYA SEVEN

GT: 3001

IMO: 9087312

Flag: India (Grey List)

Company: GOL Offshore Ltd

Classification Society: IRS

Recognised Organisation: IRS

Recognised Organisation for ISM Doc: IRS

Recognised Organisation for ISM SMC: IRS

Date and Place of Detention: 5th October 2016 at Aberdeen

Summary: Five deficiencies with five grounds for detention

Defective item	Nature of defect	Ground for Detention
07105 – Fire doors/openings in fire resisting divisions	Not as required	Yes
07113 – Fire pumps and its pipes	Not as required	Yes
18203 – Wages	Missing	Yes
01220 – Seafarers employment agreement (SEA)	Invalid	Yes
18204 – Calculation and payment of wages	No records	Yes

This vessel was still detained on 30th November 2017

Vessel Name: SEA TRIDENT

GT: 964.

IMO No: 7393169.

Flag: PANAMA (white list)

Company:

Classification Society: Expired

Recognised Organisation: Expired

Recognised Organisation for ISM DOC:

Recognised Organisation for ISM SMC:

Date and Place of Detention: 17 June 2016, West Cowes

Summary: Seventeen deficiencies with seventeen grounds for detentions

Defective item	Nature of defect	Ground for Detention
01101 – Cargo ship safety equipment cert	Expired	Yes
01102 – Cargo Ship safety construction cert	Expired	Yes
01104 – Cargo ship safety radio cert	Expired	Yes
01108 – Loadline cert	Expired	Yes
01117 – IOPP (International Oil Pollution Prevention cert	Expired	Yes
01119 – International Sewage Pollution Prevention cert	Expired	Yes
01124 – International Air Pollution Prevention cert	Expired	Yes
01137 – Civil liability for bunker oil pollution damage cert	Expired	Yes
01199 – Other certs (Certificate of class)	Expired	Yes
01201 – Certificates for master and officers	Missing	Yes
10111 – Charts	Not updated	Yes
10116 – Publications Nautical	Not updated	Yes
11108 – Inflatable liferafts	Expired	Yes
11116 – Distress flares	Missing	Yes
07109 – Fixed fire fighting extinguishing installation	Not as required	Yes
07110 – Fire fighting equipment & appliances	Not as required	Yes
01140 – Declaration of Maritime Labour Compliance	Missing	Yes

This vessel was still detained on 30th November 2017

Vessel Name: CIEN PORCIENTO (General Cargo)

GT: 106.

IMO No: 8944446.

Flag: Unregistered.

Company: Open Window Inc.

Classification Society: Unclassed.

Recognised Organisation: Not applicable.

Recognised Organisation for ISM DOC: Not applicable.

Recognised Organisation for ISM SMC: Not applicable

Date and Place of detention: 4 March 2010, Lowestoft

Summary: Thirty deficiencies including seven grounds for detention

This vessel was still detained on 30th November 2017

Notes to Editors

• The MCA is a partner in the Sea Vision UK campaign to raise awareness and understanding of the sea and maritime activities. Sea Vision promotes the importance and economic value of the sector and works to highlight the exciting range of activities and career opportunities available to young people within the UK growing maritime sector at www.seavision.org.uk

• Follow us on Twitter: @MCA_media

For further information please contact
Maritime and Coastguard Agency Press Office, on:
+44 (0) 2380 329 401
Press releases and further information about the agency is available here.

Secretary of State for Wales Alun Cairns said today (5 December):

On 17 March 2016 my predecessor, the right honourable member for Preseli Pembrokeshire, announced the publication of the Report of Lady Justice Macur’s Independent Review of the Tribunal of Inquiry into the abuse of children in care in the former county council areas of Gwynedd and Clwyd in North Wales since 1974.

Amongst other reasons, the Report was redacted to avoid prejudicing ongoing and upcoming criminal prosecutions and trials. Most of the redactions in this category concerned the former North Wales Police superintendent, Gordon Anglesea.

Following his criminal trial at Mold Crown Court, on 4 October Gordon Anglesea was sentenced at Mold Crown Court to twelve years’ custody for an indecent assault against one boy and three indecent assaults against another boy.

On 15 December 2016 Gordon Anglesea died in HMP Rye Hill. In light of Gordon Anglesea’s death there is no reason for his name to continue to be redacted, except where there is any risk that victims, witness or other individuals might be identified.

I have today therefore laid a revised version of the Macur Review Report with references to Gordon Anglesea reinstated except where an ongoing risk has been identified. The other redactions in the Report remain.

You can see the revised redacted version of the Report of the Macur Review online now.